taking a glp 1 Avoiding Pitfalls When GLP-1 Agonists Such as Semaglutide - Sparkle Health - GLP-1 GLP-1 and Anesthesia: Considerations and

Compr Physiol 10: 577-595, 2020

Research in the New England Journal of Medicine shows that people living with obesity and without diabetes lost an average of 21% of their total body weight in just over a year with Zepbound

Based on the above results and assessment of available research information, we adopted the adjusted Bradford Hill Criteria from previous publications and assessed the point-by-point link between GLP-1RAs and SSIBs

Based on the risk factor of morbid obesity in a young patient with papilledema and imaging features suggestive of intracranial hypertension, a diagnosis of IIH was made

Bjornstad P, Nehus E, El ghormli L, Bacha F, Libman IM, McKay S et al (2018) Insulin sensitivity and diabetic kidney disease in children and adolescents with type 2 diabetes: an observational analysis of data from the TODAY clinical trial

They work through several important mechanisms: They increase insulin release from the pancreas when blood glucose is high They reduce excess glucose release from the liver They slow stomach emptying, helping prevent sharp glucose spikes after meals They increase feelings of fullness, often reducing appetite Because these effects depend on blood glucose levels, GLP-1 medications on their own carry a very low risk of causing low blood sugar (hypoglycaemia)